Cancer cells exhibit alterations in the genes associated with glucose metabolism, including well‐characterized mutations in RAS and MYC oncogenes, dysregulation of PI3K/AKT/mTOR and LKB1/AMPK signaling pathways, and the deletion of the tumor suppressor p53.252, 253. This evidence concerns the gene MTOR and cancer.